IT IS AN ANTIPSYCHOTIC AGENT CHARACTERIZED BY ITS STRONG BLOCKING ACTION AND HIGH SELECTIVITY AGAINST DOPAMINE-2 RECEPTORS( STRONGER ACTION) AND SEROTONIN-2 RECEPTORS.
BLONANSERIN BINDS TO AND INHIBITS DOPAMINE RECEPTORS D2 AND D3 AS WELL AS THE SEROTONIN RECEPTOR 5-HT2A WITH HIGH AFFINITY 2. BLONANSERIN HAS LOW AFFINITY FOR OTHER DOPAMINE AND SEROTONIN RECEPTORS AS WELL AS MUSCARINIC, ADRENERGIC, AND HISTAMINE RECEPTORS. THIS REDUCES DOPAMINERGIC AND SEROTONERGIC NEUROTRANSMISSION WHICH IS THOUGHT TO PRODUCE A REDUCTION IN POSITIVE AND NEGATIVE SYMPTOMS OF SCHIZOPHRENIA RESPECTIVELY.